Bowtie Life Insurance Company Limited (Bowtie) was the first virtual insurance company licensed by the Hong Kong Insurance Authority. Since obtaining the licence in 2018 and raising two successful rounds of venture capital, Bowtie had developed into a reasonable size, of about a hundred employees, by early 2022. Bowtie was focused on developing and selling medical insurance products under the Voluntary Health Insurance Scheme (VHIS), while also selling term life insurance. The founders’ intention is to bring cheaper, more user-friendly insurance products directly to the mass market through online channels, while disrupting the traditional insurance industry by eliminating agents and brokers. The COVID-19 pandemic in 2020–2022 brought both opportunities and risks to the virtual insurance sector. While online purchases increased significantly during this period, the overall gloomy macroeconomic outlook put downward pressure on insurtech, fintech industries, and the venture capital that funded them. With Hong Kong’s mortality rates soaring, Bowtie had to consider the effects of the pandemic on its profitability and determine its future strategy. While continuing to focus on the VHIS segment, how should Bowtie expand into other product segments? When and how should the company expand to Mainland China and/or other neighbouring markets outside of Hong Kong?
Bowtie Life Insurance Company Limited (Bowtie) was the first virtual insurance company licensed by the Hong Kong Insurance Authority. Since obtaining the licence in 2018 and raising two successful rounds of venture capital, Bowtie had developed into a reasonable size, of about a hundred employees, by early 2022. Bowtie was focused on developing and selling medical insurance products under the Voluntary Health Insurance Scheme (VHIS), while also selling term life insurance. The founders' intention is to bring cheaper, more user-friendly insurance products directly to the mass market through online channels, while disrupting the traditional insurance industry by eliminating agents and brokers. The COVID-19 pandemic in 2020-2022 brought both opportunities and risks to the virtual insurance sector. While online purchases increased significantly during this period, the overall gloomy macroeconomic outlook put downward pressure on insurtech, fintech industries, and the venture capital that funded them. With Hong Kong's mortality rates soaring, Bowtie had to consider the effects of the pandemic on its profitability and determine its future strategy. While continuing to focus on the VHIS segment, how should Bowtie expand into other product segments? When and how should the company expand to Mainland China and/or other neighbouring markets outside of Hong Kong?
Hong Kong-headquartered SenseTime Group Inc. (SenseTime) was founded in 2014 to commercialize artificial intelligence (AI) and was a global leader in deep-learning AI, with applications in Smart Business (facial recognition), Smart City (property damage and theft detection), Smart Life (interacting with the Internet of Things to improve consumer experience), and Smart Auto (autonomous driving). December 10, 2021, was supposed to be the date for setting the offer price for SenseTime shares in the company’s global initial public offering. Instead, it was the date that Xu Li, co-founder and chief executive officer of SenseTime, learned from Hong Kong Clearings and Exchange Ltd. that American President Joe Biden was about to designate SenseTime a Communist Chinese Military Company—an action that prevented American investors from legally investing in SenseTime, derailing the initial public offering. How should SenseTime alter its marketing, research and development, and listing strategies in the light of the American government’s actions? How would the increased tension affect the geographic, technological, and customer aspects of SenseTime’s efforts to drive business growth?
Hong Kong-headquartered SenseTime Group Inc. (SenseTime) was founded in 2014 to commercialize artificial intelligence (AI) and was a global leader in deep-learning AI, with applications in Smart Business (facial recognition), Smart City (property damage and theft detection), Smart Life (interacting with the Internet of Things to improve consumer experience), and Smart Auto (autonomous driving). December 10, 2021, was supposed to be the date for setting the offer price for SenseTime shares in the company's global initial public offering. Instead, it was the date that Xu Li, co-founder and chief executive officer of SenseTime, learned from Hong Kong Clearings and Exchange Ltd. that American President Joe Biden was about to designate SenseTime a Communist Chinese Military Company-an action that prevented American investors from legally investing in SenseTime, derailing the initial public offering. How should SenseTime alter its marketing, research and development, and listing strategies in the light of the American government's actions? How would the increased tension affect the geographic, technological, and customer aspects of SenseTime's efforts to drive business growth?
Aglaia Kong, the founder and chief executive officer of Guangdong LeapFive Technology Co. Ltd., a Chinese fabless chip design start-up, is facing a broken supply chain, with issues running from electronic design automation and core internet protocol through to fabrication, packaging, and testing in bringing up her Internet of things chip sets for industrial applications. Using fifth-generation open-source reduced instruction set computing instruction set architecture, she must assess a supply chain buffeted by severe bullwhip shortages and political headwinds, analyze her company’s strategy, and plot a course to assure it will be among the 2 per cent of Chinese chip start-ups that do not fail.
Aglaia Kong, the founder and chief executive officer of Guangdong LeapFive Technology Co. Ltd., a Chinese fabless chip design start-up, is facing a broken supply chain, with issues running from electronic design automation and core internet protocol through to fabrication, packaging, and testing in bringing up her Internet of things chip sets for industrial applications. Using fifth-generation open-source reduced instruction set computing instruction set architecture, she must assess a supply chain buffeted by severe bullwhip shortages and political headwinds, analyze her company's strategy, and plot a course to assure it will be among the 2 per cent of Chinese chip start-ups that do not fail.
Benny Chung-Ying Zee was a professor at a prestigious university in Hong Kong and founder of Health View Bioanalytic Limited (Health View). Health View offered fast, inexpensive, non-invasive assessments of the risk of stroke and Alzheimer's disease by using artificial intelligence and automatic retinal image analysis (ARIA) of pictures of patients' retinas using fundus cameras. While Health View was breaking even, Zee realized that it was not yet a success. Thus, Zee was considering how to scale up the company to realize the impact of its technology. Zee had to assess the current business model-its value proposition, target market, sales channels, and strategic partners-and determine how he could scale up and redirect Health View.
The Green Monday Group was co-founded in 2012 by Hong Kong entrepreneur David Yeung. Capitalizing on the developing global sustainability movement and the market opportunity from growth in flexitarianism, Yeung acquired a research and development company to innovate a plant-based pig meat product, OmniPork. Through product innovation, global distribution, and celebrity endorsement, Yeung was determined to bring OmniPork to global markets. He announced in 2020 that Green Monday Holdings had raised US$70 million of equity investment, the largest funding of its kind in Asia. In 2021, the question left was how those funds could be used to expand flexitarianism globally and capture new consumers of OmniPork.
Green Monday Group (GMG) was founded in 2012 with a mission to “construct a multi-faceted global ecosystem of future food that combats climate change, food insecurity, public health crisis, planetary devastation, and animal suffering.” In 2020, GMG partnered with McDonald’s in Hong Kong and launched six dishes featuring OmniPork Luncheon Meat, a plant-based meat substitute that GMG had developed. In February 2021, the chief executive officer and co-founder of GMG had to figure out how GMG could expand its partnership with McDonald’s in Hong Kong to the rest of China. McDonald’s size and potential in the rest of China far exceeded that of McDonald’s Hong Kong, and while GMG had the resources and the determination to expand, it had to decide which marketing strategy to use.
Green Monday Group (GMG) was founded in 2012 with a mission to "construct a multi-faceted global ecosystem of future food that combats climate change, food insecurity, public health crisis, planetary devastation, and animal suffering." In 2020, GMG partnered with McDonald's in Hong Kong and launched six dishes featuring OmniPork Luncheon Meat, a plant-based meat substitute that GMG had developed. In February 2021, the chief executive officer and co-founder of GMG had to figure out how GMG could expand its partnership with McDonald's in Hong Kong to the rest of China. McDonald's size and potential in the rest of China far exceeded that of McDonald's Hong Kong, and while GMG had the resources and the determination to expand, it had to decide which marketing strategy to use.
The Green Monday Group was co-founded in 2012 by Hong Kong entrepreneur David Yeung. Capitalizing on the developing global sustainability movement and the market opportunity from growth in flexitarianism, Yeung acquired a research and development company to innovate a plant-based pig meat product, OmniPork. Through product innovation, global distribution, and celebrity endorsement, Yeung was determined to bring OmniPork to global markets. He announced in 2020 that Green Monday Holdings had raised US$70 million of equity investment, the largest funding of its kind in Asia. In 2021, the question left was how those funds could be used to expand flexitarianism globally and capture new consumers of OmniPork.
Benny Chung-Ying Zee was a professor at a prestigious university in Hong Kong and founder of Health View Bioanalytic Limited (Health View). Health View offered fast, inexpensive, non-invasive assessments of the risk of stroke and Alzheimer’s disease by using artificial intelligence and automatic retinal image analysis (ARIA) of pictures of patients’ retinas using fundus cameras. While Health View was breaking even, Zee realized that it was not yet a success. Thus, Zee was considering how to scale up the company to realize the impact of its technology. Zee had to assess the current business model—its value proposition, target market, sales channels, and strategic partners—and determine how he could scale up and redirect Health View.
In late May 2020, the two founding and managing partners at Redhill Capital, in the Pearl River New City district of Guangzhou, China, were considering various reasons why the year was developing far differently than they had expected. The two-year-old venture capital firm's limited partners and investees were all shocked by the dire developments, as was the entire country and the whole world. Earlier that year, rapidly spreading outbreaks of COVID-19, which had started in Wuhan, in China's Hubei province, had led to hundreds of thousands of deaths, and many countries were closing down their borders. With the world seemingly plunging into a deep depression, the two founders of Redhill Capital were wondering about the future of their venture capital firm, which normally invested in medical technology and biotechnology. How should the company's strategy be adjusted to survive the crisis and take advantage of new opportunities in the rapidly changing world?
The chief executive officer (CEO) of the soon-to-be completed CUHK Medical Centre Ltd. (CUMC) in Hong Kong must make a decision regarding health care logistics services. The hospital’s tender board is scheduled to meet in June 2019, and the CEO must recommend whether the logistics services needed by the hospital should be provided internally or by a third-party logistics (3PL) provider, and, if a 3PL provider, which provider should be awarded the business.
The chief executive officer (CEO) of the soon-to-be completed CUHK Medical Centre Ltd. (CUMC) in Hong Kong must make a decision regarding health care logistics services. The hospital's tender board is scheduled to meet in June 2019, and the CEO must recommend whether the logistics services needed by the hospital should be provided internally or by a third-party logistics (3PL) provider, and, if a 3PL provider, which provider should be awarded the business.